Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous entity with
complex pathophysiology and manifestations. Phenomapping is the process of applying …

Heart has a recognized endocrine function as it produces several biologically active
substances with hormonal properties. Among these hormones, the natriuretic peptide (NP) …

Natriuretic peptides (NPs) are the principal expression products of the endocrine function of
the heart. They exert several beneficial effects, mostly mediated through guanylate cyclase …

Sažetak In the year 2021, the universal definition and classification of heart failure (HF) was
published that defines HF as a clinical syndrome with symptoms and/or signs caused by a …

Heart failure (HF) is a complex syndrome caused by a variety of structural or functional
cardiac abnormalities as a consequence of several involved pathophysiological pathways …

The angiotensin receptor–neprilysin inhibitor (ARNI) sacubitril/valsartan and sodium-
glucose cotransporter-2 (SGLT-2) inhibitor dapagliflozin have been shown to reduce …

Aims Sacubitril/valsartan is a first-in-class angiotensin receptor–neprilysin inhibitor (ARNI)
with a class-1 guideline recommendation. We assessed the real-world effectiveness of ARNI …

It is difficult to treat cardiorenal syndrome (CRS) in clinical practice, which is the common
reason for the death of patients. This report aimed to describe the effects of …

Introduction Heart failure with preserved ejection fraction (HFpEF) is a disease with a high
prevalence. Accounting for more than 50% of all heart failure cases, it carries a significant …

As the ultimate pathophysiological event, heart failure (HF) may arise from various
cardiovascular (CV) conditions, including sustained pressure/volume overload of the left …